| __timestamp | Ligand Pharmaceuticals Incorporated | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12122000 | 581800000 |
| Thursday, January 1, 2015 | 13380000 | 671900000 |
| Friday, January 1, 2016 | 21221000 | 876700000 |
| Sunday, January 1, 2017 | 26887000 | 857900000 |
| Monday, January 1, 2018 | 27863000 | 822200000 |
| Tuesday, January 1, 2019 | 55908000 | 778200000 |
| Wednesday, January 1, 2020 | 59392000 | 512600000 |
| Friday, January 1, 2021 | 69012000 | 681000000 |
| Saturday, January 1, 2022 | 36082000 | 662200000 |
| Sunday, January 1, 2023 | 24537000 | 910700000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Viatris Inc. and Ligand Pharmaceuticals Incorporated have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Viatris consistently allocated a significant portion of its resources to R&D, with expenditures peaking in 2023 at approximately 910% of Ligand's spending. This reflects Viatris's strategic focus on expanding its product pipeline and enhancing its competitive edge. In contrast, Ligand's R&D spending, while more modest, saw a notable increase in 2020, reaching its highest point in 2021. This suggests a targeted approach, possibly focusing on niche innovations or strategic partnerships.
These spending patterns highlight the diverse strategies within the pharmaceutical sector, where both broad and focused R&D investments can drive success.
R&D Spending Showdown: Zoetis Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated